Humankind Investments’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,081
Closed -$2.18M 80
2025
Q3
$2.18M Buy
29,081
+1,072
+4% +$80K 0.5% 29
2025
Q2
$2.07M Buy
28,009
+11,609
+71% +$808K 0.51% 30
2025
Q1
$1.32M Sell
16,400
-1,476
-8% -$127K 0.34% 46
2024
Q4
$1.4M Buy
17,876
+1,350
+8% +$115K 0.35% 39
2024
Q3
$1.55M Buy
16,526
+176
+1% +$14.8K 0.56% 30
2024
Q2
$1.27M Buy
16,350
+4,309
+36% +$351K 0.34% 41
2024
Q1
$1.09M Sell
12,041
-1,096
-8% -$91.2K 0.29% 45
2023
Q4
$1.02M Sell
13,137
-967
-7% -$67.7K 0.3% 43
2023
Q3
$960K Buy
14,104
+1,861
+15% +$135K 0.4% 35
2023
Q2
$995K Buy
12,243
+6,605
+117% +$527K 0.39% 37
2023
Q1
$462K Buy
+5,638
New +$403K 0.19% 70

Other funds holding GEHC

Humankind Investments's GEHC Position: Q4 2025 in Review

Humankind Investments sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 29,081 shares — an estimated $2.18M sold.

Humankind Investments first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $2.18M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Humankind Investments reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 29,081 GE HealthCare shares in Q4 2025, an estimated $2.18M.
  • Humankind Investments first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Humankind Investments's GE HealthCare position peaked at $2.18M in Q3 2025.
  • 1,333 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.